Health Economics & Outcome Research

Health Economics and Outcomes Research (HEOR) is a critical function for the pharmaceutical and life science companies which is to generate robust evidence of the value of new drugs or interventions.


Our HEOR team establishes and measures the correlation between treatments and actual outcomes, providing evidence-based guidance for care improvement. We go beyond the confines of well-controlled clinical trials, considering not only clinical outcomes in real-world settings but also financial implications, quality of life, and satisfaction levels of patients and providers. As a result, our HEOR capabilities have become an increasingly powerful tool for payers, providers, patients, and caregivers in making informed healthcare decisions. Trust us to deliver comprehensive insights that drive value and enhance patient care.

Our Insights on Data, Technology, and Healthcare
Systematic Literature Reviews and AI: A Gold Standard Meets Innovation
Jun 01, 2025
Discover how Systematic Literature Reviews (SLRs) provide a gold-standard method for evidence synthesis in biomedicine—and how AI is transforming the process. Learn the key steps, differences from other review types, and the future potential of automation in research....
Read more
Is Life Science Ready for AI?
Jan 01, 2025
A few days ago, Dr. Geoffrey Hinton, often referred to as the “Godfather of AI,” made a chilling statement: “There is a 10-20 percent probability that...
Read more
Polygon Health Analytics Receives Competitive SBIR Grant from NIMHD to Address Health Disparities in Lupus Care
Nov 19, 2024
Philadelphia, PA — Nov 19, 2024 — Polygon Health Analytics LLC is proud to announce its award of a $295,924 Small Business Innovation Research (SBIR) Phase I...
Read more
View all